These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17234271)

  • 1. Rapid detection of CAA/CAG repeat polymorphism in the AIB1 gene using DHPLC.
    Kleibl Z; Havranek O; Prokopcova J
    J Biochem Biophys Methods; 2007 Apr; 70(3):511-3. PubMed ID: 17234271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG; Chang JH; Gertig DM; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
    Breast Cancer Res; 2005; 7(3):R353-6. PubMed ID: 15987430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
    Colilla S; Kantoff PW; Neuhausen SL; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Brown M; Weber BL; Rebbeck TR
    Carcinogenesis; 2006 Mar; 27(3):599-605. PubMed ID: 16244359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
    Hughes DJ; Ginolhac SM; Coupier I; Barjhoux L; Gaborieau V; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Sobol H; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Yannoukakos D; Mazoyer S; Lynch HT; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
    Int J Cancer; 2005 Nov; 117(2):230-3. PubMed ID: 15900600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Spurdle AB; Antoniou AC; Kelemen L; Holland H; Peock S; Cook MR; Smith PL; Greene MH; Simard J; Plourde M; Southey MC; Godwin AK; Beck J; Miron A; Daly MB; Santella RM; Hopper JL; John EM; Andrulis IL; Durocher F; Struewing JP; Easton DF; Chenevix-Trench G; ; ; ; ; ;
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):76-9. PubMed ID: 16434590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of C677T mutation in methylenetetrahydrofolate reductase gene by denaturing high performance liquid chromatography.
    Fang N; Lin L; Ren J; Wu D
    Biomed Chromatogr; 2004 Nov; 18(9):625-9. PubMed ID: 15386507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography.
    Etokebe GE; Abrahamsen TG; Bogen B; Spurkland A
    Scand J Immunol; 2004 May; 59(5):496-503. PubMed ID: 15140060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer.
    Wilkening S; Burwinkel B; Grzybowska E; Klaes R; Pamula J; Pekala W; Zientek H; Hemminki K; Försti A
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):291-2. PubMed ID: 15668512
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of single-nucleotide polymorphisms in insulin receptor substrate-2 gene 3'-untranslated region by denaturing high-performance liquid chromatography].
    Zeng WM; Chen SH; Xie P
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):317-21. PubMed ID: 14653106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
    Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
    Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
    Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
    J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of NCOA3 polymorphisms with breast cancer risk.
    Burwinkel B; Wirtenberger M; Klaes R; Schmutzler RK; Grzybowska E; Försti A; Frank B; Bermejo JL; Bugert P; Wappenschmidt B; Butkiewicz D; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Bartram CR; Hemminki K
    Clin Cancer Res; 2005 Mar; 11(6):2169-74. PubMed ID: 15788663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development.
    Kleibl Z; Havranek O; Kormunda S; Novotny J; Foretova L; Machackova E; Soukupova J; Janatova M; Tavandzis S; Pohlreich P
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):331-8. PubMed ID: 20422428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
    Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the hamartin gene using denaturing high performance liquid chromatography.
    Bénit P; Kara-Mostefa A; Berthelon M; Sengmany K; Munnich A; Bonnefont JP
    Hum Mutat; 2000 Nov; 16(5):417-21. PubMed ID: 11058899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatography.
    Ezzeldin H; Hoffmayer C; Soong R; Johnson MR; Lee A; Heslin M; Diasio R
    Anal Biochem; 2004 Nov; 334(2):276-83. PubMed ID: 15494134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of glucose-6-phosphate dehydrogenase gene mutations by denaturing high-performance liquid chromatography.
    Tseng CP; Huang CL; Chong KY; Hung IJ; Chiu DT
    Clin Biochem; 2005 Nov; 38(11):973-80. PubMed ID: 16137669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
    Fackenthal DL; Chen PX; Das S
    Methods Mol Biol; 2005; 311():73-96. PubMed ID: 16100401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.